K13 and K19 DARPins selectively inhibit the PI3K/AKT pathway in the KRAS mutant HCT116 cell line, but not in the other cancer cell lines, while K27 inhibits this pathway in HCT116 and MCF-7 cells (Fig. 5a, b). Here, KRAS is linked to cancer.